Ourvita key facts
- Provider of outsourced contract development and manufacturing services intended to serve pharmaceutical companies.
- It has raised $319.8M; the latest was PE Growth/Expansion in Aug 2025.
- Notable investors include Investindustrial, Ardian France, Doppel Farmaceutici.
- Status: Privately Held (backing).
Who backs Ourvita
3- ·Watch Ourvita: the Monday email on marks, rounds and moves
Ourvita funding rounds
No funding rounds for Ourvita are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ourvita investors
3 investors are on record for Ourvita, including Investindustrial, Ardian France and Doppel Farmaceutici.
About Ourvita
Provider of outsourced contract development and manufacturing services intended to serve pharmaceutical companies. The company's offerings include the development, production and packaging of food supplements, medical devices and cosmetics, enabling clients to get access to regulatory support, clinical trial services, and stability studies.
- Sector
- Business Products and Services (B2B)
- HQ
- Bergamo, Italy
- Founded
- 1939
- Employees
- 3,000
- Website
- ourvita.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Ourvita doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.